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Cellular pathways involving a-synuclein (aS) seem to be causative for development of Parkinson’s
disease. Interactions between aS and lipid membranes appear to be important for the physiological
function of the protein and inﬂuence the pathological aggregation of aS leading to the formation of
amyloid plaques. Upon membrane binding the unstructured aS folds into amphipathic helices. In
our work we characterized the penetration depth and probed the local environment of Trp-residues
introduced along the aS sequence. We could show that while the entire helix is well embedded in
the lipid bilayer, segments with a shallower penetration and supposable higher ﬂexibility exist.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
One of the most widespread neurodegenerative diseases is Par-
kinson’s Disease (PD) [1]. Yet, the causative factors remain a mys-
tery. While the most causes of PD are still considered idiopathic,
several genetic factors contributing to PD have been identiﬁed.
One gene among these, codes for the 14.5-kDa, 140-amino acid
protein a-synuclein (aS). E.g., three point mutations as well as
gene triplication relate with inherited forms of PD [2–6]. Addition-
ally large intracellular protein aggregates, the Lewy Bodies, which
are a hallmark of PD, are rich in amyloid aS-ﬁbrils [7]. While the
exact function of aS has not been identiﬁed yet, strong evidence
exists, that the protein is involved in the regulation of the synaptic
vesicle reserve pool [8–11]. Here a direct interaction of aS with the
lipid bilayer is likely, as many in vitro experiments have shown that
the protein shows afﬁnity towards membranes containing nega-
tively charged lipids. While aS belongs to the class of intrinsically
disordered proteins, when bound to lipid membranes the N-termi-
nus folds into an amphipathic helix. However, the exact shape of
the helix depends on the properties of the lipid model system used.
Both, an extended single helix as well as two separate helices con-
nected by a short ﬂexible linker in a horse shoe orientation havebeen observed, also a transition between both forms seems possi-
ble [12–17]. As membrane binding seems to be not only a prere-
quisite for the physiological function of aS, but also has an
impact on the aggregation of the protein towards the toxic mis-
folded forms, understanding the aS membrane interactions in
depth may yield clues towards the causative factors of PD. While
many experiments suggest that the helices orient parallel to the
membrane surface, the exact organization of the protein on the
surface remains in the focus of research. To determine the penetra-
tion of the aS helix into lipid bilayers we have used tryptophan
(Trp) ﬂuorescence spectroscopy to characterize the immersion of
aS residues into the lipid bilayer. While a similar approach has al-
ready been described earlier, this work focused only on a few se-
lected positions [18]. In contrast, we have introduced Trp at
many positions throughout the whole sequence of aS to get a de-
tailed view about the interactions of speciﬁc regions.
2. Materials and methods
2.1. Materials
POPC and POPS were purchased from Avanti Polar Lipids (Ala-
baster, AL, USA), acrylamide and HEPES from Carl Roth GmbH (Kar-
lsruhe, Germany). All other reagents were analytical grade.
2.2. Expression and puriﬁcation of a-synuclein mutants
The different mutations (L8W, V15W, G25W, V26W, T33W,
Y39W, V48W, A56W, V63W, G73W, V74W, T75W, I88W, F94W,
Fig. 1. Sequence and structure properties of aS. a-Helical structure of SDS bound aS
is shown as grey solid bar, while unstructured regions are shown as solid black line.
(Based on PDB entry 1XQ8) [32] Trp substitutions are highlighted in bold black.
J. Wietek et al. / FEBS Letters 587 (2013) 2572–2577 2573V95W) were generated by site-directed mutagenesis. Expression in
Escherichia coli Rosetta (DE3) pLysS cells as well as puriﬁcation was
performed as described in [19]. Protein variants were stored at
78 C. Protein concentrations were determined by UV absorption.
2.3. Production of large unilamellar vesicles (LUV)
LUV were produced as speciﬁed in Ref. [20]. The phospholipid
chloroform mixture was evaporated with nitrogen in a glass vial.
HEPES buffer (50 mM HEPES, pH 7.0) was added to get a lipid con-
centration of 4 mM. The solution was subjected to ﬁve freeze thaw
cycles (56 C (10 min), 50 C (5 min)). The resulting multilamellar
vesicles were extruded 10 times through a 100 nm Nuclepore
track-etched polycarbonate membrane (Whatman plc, Maidstone,
UK). Dynamic light scattering measurements of LUV preparations
showed a single size distribution centered at a diameter of
91 nm (data not shown). LUV were stored at 4 C and used within
2 days.
2.4. Sample preparation and quenching assay
All samples were prepared at room temperature and incubated
at least 25 min at 25 C before use. For assessing binding afﬁnity
and population heterogeneity, aS variants (ﬁnal concentration
0.4 lM) were mixed with LUV (ﬁnal lipid concentrations: 0; 50;
100; 200; 400; 500 lM). For acrylamide quenching concentrations
of lipids and aS were 0 or 625 lM and 0.5 lM, respectively. Acryl-
amide from a 2 M stock solution was added in 3 ll aliquots to an
initial sample volume of 140 ll. All samples and LUV dilutions
were made with the HEPES buffer (50 mM HEPES, pH 7.0).
2.5. Fluorescence measurements
All samples were measured at 25 C in ultra-micro 10  2 mm
quartz cuvettes (Hellma GmbH, Mülheim, Germany) with a Fluoro-
max-4 (HORIBA Jobin Yvon, Edison, NJ, USA). Emission and excita-
tion bandpass were set to 4 nm. Emission spectra were recorded
from 305 nm to 460 nm ðkex ¼ 295 nmÞ and averaged over two sin-
gle spectra. Integration time was set to 500 ms. For quenching
experiments spectra were recorded from 305 nm to 400 nm with
an integration time of 200 ms. Spectra were corrected for buffer,
LUV contributions and for the instrument response.
2.6. a-Synuclein membrane binding afﬁnities
To determine the molar partition coefﬁcient KL the fraction of
bound protein was plotted against the lipid concentration and ﬁt-
ted to the Langmuir isotherm [21,22]:
1 Pf ¼ Pb ¼ Pt KLLa1þ KLLa ð1Þ
where Pt is the total amount of proteins. La is the concentration of
available lipid binding sites, i.e., the negatively charged lipids in
the outer leaﬂet of the LUV membrane corresponding to 25% of
the total lipid concentration. Pb is the fraction of bound proteins
and was calculated as described in Eq. (1). The fraction of unbound
protein was determined by ﬁtting the spectra by a linear combina-
tion of two spectra corresponding to bound and unbound aS,
respectively. Binding afﬁnities are shown as reciprocal molar parti-
tion coefﬁcients.
2.7. Environmental and/or conformational population heterogeneity
To get information about environmental and conformational
population heterogeneity, emission spectra were ﬁtted to a
log-normal distribution to estimate the peak widths C at halfmaximum intensity Imax and the peak wavelength kmax correlate
according to Ladokhin et al. [23]:
k > kmax  qCq21 ; IðkÞ ¼ Imaxexp ln2ln2q ln
2 1þ kkmaxð Þ q
21ð Þ
qC
  
k < kmax  qCq21 ; IðkÞ ¼ 0
ð2Þ
Here q describes the asymmetry of the distribution. Cwas plot-
ted as a function of kmax and compared with reference data.
2.8. Fluorescence quenching of tryptophan by acrylamide
The ﬂuorescence intensity was determined by integrating the
spectrum from 305 nm to 400 nm. Because the titration with acryl-
amide decreases the concentration of ﬂuorophores, data were cor-
rected for dilution according to Ref. [24]. The inner ﬁlter effect due
to the absorption of excitation light ðeacrylamide295 ¼ 0:24 M1 cm1Þ of
added acrylamide was corrected as described in Lakowicz [25].
Absorption of emitted ﬂuorescence was neglected. The corrected
ﬂuorescence was plotted and ﬁtted according to the modiﬁed
Stern–Volmer equation:
F0
F
¼ 1þ KSV½Q ð ÞeV ½Q  ð3Þ
where F0 and F are the ﬂuorescence intensities in the absence and
presence of quencher, respectively, KSV is the Stern–Volmer con-
stant, [Q] is the molar concentration of quencher, and V is the static
quenching constant.
3. Results
LUV were used as model for lipid bilayers, as these vesicles are
ideally suited for ﬂuorescence spectroscopy. Having a diameter of
approx. 100 nm they are sufﬁciently large that membrane curva-
ture and packing defects can be neglected. A POPC/POPS (1/1) lipid
mixture provides a target membrane for efﬁcient binding of aS. We
have shown that binding of aS to membranes requires negatively
charged lipids in a disordered ﬂuid phase environment [19]. To
characterize membrane binding and possible embedding of aS se-
quences into the bilayer we utilized Trp ﬂuorescence spectroscopy.
This technique relies on the property of the Trp ﬂuorescence emis-
sion to shift to shorter wavelengths and increase in quantum yield
when embedded into an apolar environment as opposed to the po-
lar aqueous buffer. As aS is devoid of Trp, for the measurements
single Trp residues were introduced at speciﬁc positions (Fig. 1).
The ability of the mutants to adopt a-helical structure upon mem-
brane binding similar to that found previously for the wild type
was conﬁrmed by CD experiments (see examples in Supplemen-
tary information).[26]
We measured whether the introduced Trp residues affected the
binding afﬁnity of aS towards the POPC/POPS LUV. To this end the
different aS variants were incubated with different concentrations
of LUV and the ﬂuorescence spectra were recorded (Fig. 2a). The
fractions of bound and unbound protein were determined as de-
scribed in Section 2. These data were ﬁtted by Langmuir isotherms
2574 J. Wietek et al. / FEBS Letters 587 (2013) 2572–2577(Eq. (1)) to obtain the respective binding constants (Fig. 2a, inset,
and Fig. 2b).
We could not detect any signiﬁcant difference in membrane
afﬁnity between the aS variants indicating that the single mutation
introducing tryptophan does not affect the binding afﬁnity. Note,
we could not apply this approach to variants with Trp in positions
88–95 as these residues did not insert into the membrane (see be-
low). To ensure that all aS is bound, in the following experiments a
high lipid concentration well above the measured binding afﬁnity
was used.
Embedding of the Trp residues into the bilayer was assessed by
their protection from the hydrophilic quencher acrylamide. A low-
er quenching and thus a lower Stern–Volmer constant for a given
residue in the presence of vesicles would indicate its protection
from the quencher and hence its insertion into lipid bilayer (Fig. 3).
While constantly high quenching ratios and Stern–Volmer con-
stants for all Trp positions are observed in the absence of LUV,
which is in line with the intrinsically disordered nature of aS in
solution, a protection of the Trp residues in position 8 through
75 was observed in the presence of LUV. However, no attenuation
of ﬂuorescence quenching occurs for the positions 88, 94 and 95,
indicating that Trp in these positions does not become embedded
in the hydrophobic membrane core. Strikingly for the consecutive
positions 26 and 27 and 73–75 in each case an equally strong pro-
tection is observed, despite the fact that the Trp residues are
spread about 100 and 180, along a predicted helical wheel
(Fig. 6, see Section 4). This indicates that the aS helix is well
embedded in the lipid bilayer in these regions.300 350 400 450
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Fig. 3. Accessibility of the different Trp mutants to acrylamide. (a) Quenching ratio F0/F at
625 lM POPC/POPS 1/1 LUV. (b) Stern–Volmer constants Ksv for the aS variants. Ksv an
concentration was 0.5 lM. Error bars indicate S.E.M. of measurements (a) and ﬁts (b). (Alternatively the penetration of Trp into the hydrophobic bi-
layer core can be measured by the sensitivity of the Trp ﬂuores-
cence towards the polarity of its environment (see above). The
spectral changes upon binding of the respective aS variants to
LUV are plotted in Fig. 4.
While a pronounced shift of the emission maximum towards
shorter wavelengths can be observed for the Trp residues in the
positions 8 through 75, membrane binding has only a minor im-
pact on the emission for positions 88, 94 and 95. Thus, the ob-
served spectral changes agree with the protection of the Trp
probes from the acrylamide quencher, corroborating the embed-
ding of at least the ﬁrst 75 residues into the membrane core. How-
ever, the emission spectra seem to be more sensitive to changes in
the environment of the Trp probe. While in the quenching experi-
ments the degree of protection from the quencher was virtually
unchanged for all positions tested up to residue 75, an attenuated
blueshift of the emission maximum, in line with an absent increase
in ﬂuorescence intensity, is observed for Trp in the positions 39, 48
and 63. Also Trp at position 75 shows a less pronounced blueshift.
This indicates that in these cases the probe senses a more polar
environment, while the protection from the acrylamide is still re-
tained, suggesting that the residue is still embedded in the bilayer
but resides less close to the hydrophobic core.
Additionally the shape of the Trp emission spectrum yields
information about the heterogeneity of the measured ensemble.
As the emission follows a log-normal distribution, a relation be-
tween the wavelength of the emission maximum and the half max-
imum width of the spectrum exists [23]. Thus, spectral broadening8 15 25 26 33 39 48 56 63 73 74 75 88 94 95
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for different lipid concentrations thus yields insight about the
binding mechanism. Exemplary emission spectra and spectral
characteristics for the aS variants are shown in Fig. 5.
The data show that the residual heterogeneity of the sample is
quite low for the highest lipid concentrations irrespective of the
Trp position, indicating that most of aS is bound to LUV. For inter-
mittent lipid concentrations in most cases heterogeneity, although
with varying degree, was found. However, for the aS-variants 39,
63 and 75 no signiﬁcant heterogeneity can be observed (see
Section 4).
4. Discussion
Several lines of evidence suggest that aS is involved in the reg-
ulation of fusion of synaptic vesicles. aS hereby might act by
changing the properties of the lipid bilayer it binds to, thereby
impacting the fusion efﬁciency. In addition, membrane interac-
tions seem to change the aggregation properties of the protein.
However, not much about a biological relevant organization of
aS at negatively charged bilayers is known. While structures of li-
pid bound aS conﬁrming the existence of a helical wheel have been
published, the measurements were performed using SDS micellesor small unilamellar vesicles [17,26,27]. However, these entities
suffer from the presence of a high curvature and therefore do not
match the physiological situation as the presence of packing de-
fects may change conformation of the membrane bound aS. Indeed
MD simulations have shown that differences between the organi-
zation and ﬂexibility of the bound aS between bilayers and mi-
celles exist [28].
In order to elucidate the conformation of monomeric aS and its
penetration depth into the bilayer, we used Trp ﬂuorescence spec-
troscopy. While this approach had been applied before, only a few
positions were probed and POPA was used as negatively charged
lipid [18], which shows a differing behavior to the physiologically
predominant PS in binding studies [29]. We applied an extensive
array of single Trp point mutations to probe positions along the
aS sequence. As mainly hydrophobic amino acids were chosen
for mutation the introduced mutations should not affect the bind-
ing behavior of aS. In fact, our measurements showed that in no
case the exchange of an amino acid for Trp changed the binding
afﬁnity of aS.
We probed the accessibility of Trp in different positions to
aqueous solutions using the ﬂuorescence quencher acrylamide.
The experiment showed that the introduced Trp residues in posi-
tion 8–75 become well protected upon membrane binding of aS,
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as suggested by Jao et al. and Perlmutter et al. [17,28]. As for resi-
dues 39 and 75, which are located on the ‘‘back’’, i.e., the hydro-
philic part of the helix (Fig. 6), are expected to face the aqueous
solution, an equally strong protection from the quencher was ob-
served. This is consistent with result of MD simulations [28] show-
ing that the two helices are fully embedded in the lipid bilayer up
at a depth of 3–5 Å beneath the lipid headgroup phosphates. The
authors concluded a tighter interaction of aS with lipids than with
detergent micelles. The C-terminal residues are exposed to the
aqueous environment even when bound to the bilayer, which is
in agreement with previous studies, indicating that the negatively
charged C-terminus remains unstructured and does not take part
in binding [18].
To probe the polarity of the Trp environment, the blueshift of
the maximum intensity of the ﬂuorescence emission and the in-
crease in ﬂuorescence intensity were measured. For all well pro-
tected positions, with the exception of the positions 39, 48, 63
and 75, a substantial blueshift and increase in intensity was ob-
served upon binding, which indicates an apolar environment and
agrees well with the strong protection from the quencher. For
the positions 39, 48, 63 and 75 the blueshift and ﬂuorescence in-
crease was less extensive, suggesting a more polar environment.
While this can be explained by their position on the helical wheel
for the probes located at residues 39 and 75, positions 48 and 63
should be deeply embedded in the hydrophobic core of the bilayer.
The exposure of these residues could be explained by a curved he-
lix, which brings these positions closer to the surface of the lipid
bilayer, or by local deviations from a helical structure. Indeed,
MD simulation revealed that the turn region of the horse shoe like
arranged two helices at residues 39–46 projects outward and is of
high ﬂexibility [28]. This would be in line with a less extensive
blueshift and increase in ﬂuorescence of residues 39 and 48.
To yield insights into the membrane binding mechanism of aS,
we recorded emission spectra of the Trp probes for different lipid
concentrations, therefore probing the transition from an unbound
protein to the fully membrane bound protein. For a gradual bind-
ing process at intermediate concentrations, when only a part of
the aS molecules are already bound at the bilayer, a broadening
of the Trp emission spectrum, due to the overlay of the spectra
of the bound and free molecules, should occur. This can be ob-
served for most of the positions probed in our assay. However,for the residues 39, 63 and 75 a linear dependence between the
width and the maximum intensity of the ﬂuorescence emission
can be observed (Fig. 5b). Strikingly, these residues show an atten-
uated increase in the shift of the emission maximum and the inten-
sity upon membrane binding (Fig. 4). At this stage we can only
hypothesize about the molecular background for this unusual
behavior. At least for residue 39 the reported high ﬂexibility (see
above and [28]) could provide an explanation. Interestingly, MD
simulation unraveled a strong bending of the helix close to residue
63 [28].
In conclusion, our study is consistent with a helical structure of
aS mainly embedded in the lipid bilayer up to residue 75, while the
C-terminus is exposed to aqueous environment of the membrane.
Although our data do not provide information on a horse shoe like
organization, the exposure of residues 39, 48, 63 and 75 could pro-
vide an indication for the existence of ﬂexible regions. Our results
would not necessarily contradict the results by Langen and co-
workers based on site-directed spin-labeling aS [17,27]. EPR spec-
tra along the entire membrane-bound protein and accessibility of
spin-label to colliders indicated an extended, curved membrane
embedded a-helical structure with high ﬂexibility. Different to
our study small unilamellar vesicles have been used, raising again
the issue how curvature may affect organization of aS.
While membrane bound aS is in general adopts a helical struc-
ture, many experiments indicate that the protein can ﬂexibly adapt
to the different conditions, like membrane curvature, type of lipids
or protein to lipid ratio (for a extensive review see [30]). In a phys-
iological context, segments with an increased ﬂexibility would
facilitate the transformation of aS from an extended helix to the
horse shoe conﬁrmation, what might play an important role in
its proposed function in the regulation of synaptic vesicle fusion
during neurotransmitter release [30,31].Acknowledgments
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